Oral semaglutide
Sold by Prime Doctor RX · Oral tablet · every oral semaglutide record
Price
| Term | Published rate | Charged today |
|---|---|---|
| Month-to-month, billed every 4 weeksAdvertised “Oral Semaglutide A non-injection semaglutide option for eligible patients when clinically appropriate. $209 / mo* Month-to-month: $279 every 4 weeks 12 weeks upfront $777 · $259/mo 24 weeks upfront $1,434 · $239/mo 52 weeks upfront $2,717 · $209/mo” | $279Per 4 weeks | Charged today$279 |
| 12 weeks paid upfront “Oral Semaglutide A non-injection semaglutide option for eligible patients when clinically appropriate. $209 / mo* Month-to-month: $279 every 4 weeks 12 weeks upfront $777 · $259/mo 24 weeks upfront $1,434 · $239/mo 52 weeks upfront $2,717 · $209/mo” | $777Per 12 weeks | Charged today$777 |
| 24 weeks paid upfront “Oral Semaglutide A non-injection semaglutide option for eligible patients when clinically appropriate. $209 / mo* Month-to-month: $279 every 4 weeks 12 weeks upfront $777 · $259/mo 24 weeks upfront $1,434 · $239/mo 52 weeks upfront $2,717 · $209/mo” | $1,434Per 24 weeks | Charged today$1,434 |
| 52 weeks paid upfront “Oral Semaglutide A non-injection semaglutide option for eligible patients when clinically appropriate. $209 / mo* Month-to-month: $279 every 4 weeks 12 weeks upfront $777 · $259/mo 24 weeks upfront $1,434 · $239/mo 52 weeks upfront $2,717 · $209/mo” | $2,717Per 52 weeks | Charged today$2,717 |
Price sources
- Month-to-month, billed every 4 weeks · primedoctorrx.com — read September 2026
- 12 weeks paid upfront · primedoctorrx.com — read September 2026
- 24 weeks paid upfront · primedoctorrx.com — read September 2026
- 52 weeks paid upfront · primedoctorrx.com — read September 2026
We earn nothing from this link. It opens Prime Doctor RX's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | Not disclosed |
| Prescriber | Asynchronous review |
| Cancellation | You may request cancellation of a month-to-month plan at any time. Cancellation stops future renewals; it does not automatically reverse a charge for a service period that has already begun. To help prevent the next scheduled renewal from processing, submit your cancellation request at least 72 hours before your next billing date. |
| Membership | Not disclosed |
| Consult fee | None. “No hidden fees. Fees are shown before enrollment. Refunds can be requested at any time except for a month in which medication has already been ordered.” |
Recorded from primedoctorrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Prime Doctor RX quotes its own upfront totals beside each prepaid tier, so nothing here is multiplied out. Its month-to-month tier is billed every four weeks, not monthly: the plan cards read “$249 every 4 weeks” and the billing policy says charges run “on a recurring cycle, commonly every 28 days”. Thirteen such charges fall in a year rather than twelve, so the month-to-month figure recorded here is the company's own per-cycle price and not an annualized twelfth. The 52-week totals likewise exceed twelve times the advertised effective monthly rate, because that rate is stated over thirteen four-week cycles.
- 2. September 2026 — Luvo Health (luvohealth.com) publishes an identical charge for every tier and every product on this list: $249, $657, $1,194 and $2,327 for injectable semaglutide, $339, $927, $1,734 and $3,497 for tirzepatide, $279, $777, $1,434 and $2,717 for the oral tablet. Two companies with different names, different sites and separate affiliate programs are selling one price book.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.